PRLD
Prelude Therapeutics Inc SEC filings
Every EDGAR filing for Prelude Therapeutics Inc (PRLD), newest first, with AI summaries and stories.
- Ticker
- PRLD
- CIK
- 1678660
- Latest filing
- Sep 10
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Filings
8-KPrelude Therapeutics IncPRLDLIVE 10-QPrelude Therapeutics IncPRLDLIVE 8-KPrelude Therapeutics IncPRLDLIVE SCHEDULE 13GPrelude Therapeutics IncPRLDLIVE Ownership stake disclosure by Soleus Private Equity Fund III, L.P.
Soleus Private Equity Fund III, L.P., filed by
4Prelude Therapeutics IncPRLDLIVE 6 insider filings
Julian Baker, insider filing for PRLD
Show all 6
- 4Insider filing for PRLD
- 4Insider filing for PRLD
- 4Insider filing for PRLD
- 4Insider filing for PRLD
- 4Insider filing for PRLD
- 4Insider filing for PRLD
Julian Baker, reporting · Felix Baker, reporting · +4 more
8-KPrelude Therapeutics IncPRLDLIVE 10-QPrelude Therapeutics IncPRLDLIVE 8-KPrelude Therapeutics IncPRLDLIVE 4Prelude Therapeutics IncPRLDLIVE Charles Q Morris, insider filing for PRLD
Charles Q Morris, reporting
ARSPrelude Therapeutics IncPRLDLIVE DEF 14APrelude Therapeutics IncPRLDLIVE DEFA14APrelude Therapeutics IncPRLDLIVE SCHEDULE 13GPrelude Therapeutics IncPRLDLIVE Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P., filed by
4Prelude Therapeutics IncPRLDLIVE 2 insider filings
RA Capital Healthcare Fund LP, insider filing for PRLD
Show all 2
- 4Insider filing for PRLD
- 3New insider at PRLD
RA Capital Healthcare Fund LP, reporting · RA CAPITAL MANAGEMENT, L.P., reporting · +2 more
SCHEDULE 13D/APrelude Therapeutics IncPRLDLIVE Ownership stake disclosure by ORBIMED ADVISORS LLC (amended)
ORBIMED ADVISORS LLC, filed by
4Prelude Therapeutics IncPRLDLIVE 2 insider filings
David P Bonita, insider filing for PRLD
Show all 2
- 4Insider filing for PRLD
- 4Insider filing for PRLD
David P Bonita, reporting
SCHEDULE 13D/APrelude Therapeutics IncPRLDLIVE Ownership stake disclosure by BAKER BROS. ADVISORS LP (amended)
BAKER BROS. ADVISORS LP, filed by
4Prelude Therapeutics IncPRLDLIVE Julian Baker, insider filing for PRLD
Julian Baker, reporting · Felix Baker, reporting · +4 more
8-KPrelude Therapeutics IncPRLDLIVE 3Prelude Therapeutics IncPRLDLIVE Charles Q Morris, new insider at PRLD
Charles Q Morris, reporting
8-KPrelude Therapeutics IncPRLDLIVE 3Prelude Therapeutics IncPRLDLIVE Sean P. Brusky, new insider at PRLD
Sean P. Brusky, reporting
424B5Prelude Therapeutics IncPRLDLIVE 8-KPrelude Therapeutics IncPRLDLIVE S-8Prelude Therapeutics IncPRLDLIVE 10-KPrelude Therapeutics IncPRLDLIVE 8-KPrelude Therapeutics IncPRLDLIVE SCHEDULE 13G/APrelude Therapeutics IncPRLDLIVE Ownership stake disclosure by Krishna Vaddi (amended)
Krishna Vaddi, filed by
4Prelude Therapeutics IncPRLDLIVE 4 insider filings
Andrew Combs, insider filing for PRLD
Show all 4
- 4Insider filing for PRLD
- 4Insider filing for PRLD
- 4Insider filing for PRLD
- 4Insider filing for PRLD
Andrew Combs, reporting
8-KPrelude Therapeutics IncPRLDLIVE 8-KPrelude Therapeutics IncPRLDLIVE EFFECTPrelude Therapeutics IncPRLDLIVE S-3Prelude Therapeutics IncPRLDLIVE 10-QPrelude Therapeutics IncPRLDLIVE 8-KPrelude Therapeutics IncPRLDLIVE 4Prelude Therapeutics IncPRLDLIVE Victor Sandor, insider filing for PRLD
Victor Sandor, reporting
SCHEDULE 13GPrelude Therapeutics IncPRLDLIVE Ownership stake disclosure by INCYTE CORP
INCYTE CORP, filed by
8-KPrelude Therapeutics IncLIVE